by AIP Online Bureau | Jun 29, 2021 | Eco/Invest/Demography, Facts, Health, Life, Non-Life, Pandemic
Amid the global shortage of the COVID-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. According to the study,...
by AIP Online Bureau | Jun 29, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic
New Delhi: Five Indian generic drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial in India for Merck & Co's experimental anti-viral drug to treat mild COVID-19 in non-hospitalised patients....
by AIP Online Bureau | Jun 29, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic
New Delhi: Johnson & Johnson on Tuesday said it is in talks with the Indian government to explore ways to accelerate delivery of its single dose COVID-19 vaccine in the country. The company also said as per a recent announcement by the Indian drug...
by AIP Online Bureau | Jun 29, 2021 | Eco/Invest/Demography, Indian News, Regulation
Mumbai: Seeking to strengthen the corporate governance practices as well as attract more investors, markets watchdog Sebi on Tuesday approved stricter norms related to independent directors, reduced the minimum subscription amount for REITs and InvITs and...
by AIP Online Bureau | Jun 29, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic
New Delhi: India's drug regulator may soon grant restricted emergency use authorization for Moderna's COVID-19 vaccine, official sources said on Tuesday. Cipla filed an application on Monday seeking permission for import of Moderna's COVID-19...
